GeneralConnection.com ➔ Dictionary
Dictionary Search

haemophilia b

Synonyms

Noun

1. hemophilia B

2. haemophilia B, Christmas disease, hemophilia, haemophilia, bleeder's disease

Usage
9 Myths and Facts About Hemophilia B - HealthCentral
Sobi to showcase new data across haemophilia portfolio at ISTH 2026 - Yahoo Finance
Single-Dose Gene Therapy Shows Promising Safety, Efficacy, and Patient-Reported Outcomes in Hemophilia B - Docwire News
Factor IX-Padua AAV gene therapy in hemophilia B: phases 1/2 and 3 trials - Nature
Final Analysis of a Study of Etranacogene Dezaparvovec for Hemophilia B - The New England Journal of Medicine
Explainer 2025 Why Is Hemophilia B Called Christmas Disease - Global Biotechnology Company
China’s first hemophilia B gene therapy now approved in Macao - Hemophilia News Today
EAHAD 2026: Nine-Year Outcomes of Gene Therapy - European Medical Journal
Optimization of hemophilia B treatment via population PK modeling of rIX-FP, including a 3-week regimen - Frontiers
U.S. FDA Approves Pfizer’s HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need - Business Wire
Patients With Hemophilia B Report Improvement in QoL After Gene Therapy - Hematology Advisor
Building safeguards for gene therapy in haemophilia - The Lancet
Marstacimab in the treatment of patients with hemophilia A and B - Via Medica Journals
How durable is gene therapy for haemophilia B? - Nature
4 Things to Expect for the Future of Hemophilia Treatment - Docwire News
Gene therapy can help reduce joint bleeds in hemophilia B: New data - Hemophilia News Today
European Commission Approves Pfizer’s HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors - Business Wire
Marstacimab Superior to On-Demand Prophylaxis for Hemophilia A, B, With Inhibitors - Docwire News
New gene therapy reduces bleeding rates for hemophilia B patients - Hemophilia News Today
AAV Gene Therapy in Severe Hemophilia B - The New England Journal of Medicine
Balancing the benefits and risks of rebalancing coagulation in haemophilia - The Lancet
Clinical Scenarios in Hospitalized Patients With Hemophilia - Cureus
First subject dosed in Be Biopharma’s trial of haemophilia B therapy - Clinical Trials Arena
ASH: CSL proves efficacy of hemophilia B gene therapy Hemgenix holds up after 5 years - Fierce Pharma
(marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need - Business Wire
Phase 3 Analysis: Concizumab Noninferior to Prior Prophylaxis in Hemophilia A, B, Without Inhibitors - Docwire News
Steven W. Pipe, MD, on the End-of-Study Results From Hemgenix’s HOPE-B Trial - CGTLive®
Gene therapy comes of age to staunch hemophilia B - St. Jude Children's Research Hospital
Patients With Hemophilia Face Significant Burden Despite Treatment Type or Disease Severity - Docwire News
European Commission Approves Pfizer’s Haemophilia Treatment - Healthcare Digital
CSL Canada Announces First Canadian Patient Receives HEMGENIX® (etranacogene dezaparvovec) Hemophilia B Gene Therapy in Ontario, Canada - Newswire Canada
Pfizer’s Hympavzi significantly reduces bleeds in haemophilia patients - PMLiVE
Digital tool could help people with hemophilia ‘live their normal life’ - Hemophilia News Today
Tailored collagen binding of albumin-fused hyperactive coagulation factor IX dictates in vivo distribution and functional properties - Nature
Data on ABRs in Severe Pediatric Hemophilia Key to Benchmarking Prophylaxis - Hematology Advisor
Eloctate, Alprolix control bleeds in hemophilia patients’ major surgeries - Hemophilia News Today
Nonfactor Therapies for Hemophilia: Current Evidence, Clinical Relevance and Cost Considerations - Managed Healthcare Executive
Hull teenager first to be treated with new haemophilia drug - BBC
EC approves added indication for Pfizer’s Hympavzi - The Pharma Letter
FDA Grants Priority Review For Pfizer’s Marstacimab for Hemophilia A or B - PharmTech.com
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B - The New England Journal of Medicine
FDA approves Alhemo® as once-daily prophylactic treatment to prevent or reduce the frequency of bleeding episodes for adults and children 12 years of age and older with hemophilia A or B (HA/HB) without inhibitors - PR Newswire
China Explores Weight-Based Pricing for First Domestic Hemophilia B Gene Therapy - NAVLIN DAILY
Novo Nordisk’s Alhemo approved by FDA for expanded haemophilia use - PMLiVE
Fidanacogene Elaparvovec for Hemophilia B — A Multiyear Follow-up Study - The New England Journal of Medicine
The National “New Methods” Decision Forum in Norway recommends CSL’s gene therapy HEMGENIX® for adults with severe or moderately severe haemophilia B without a history of Factor IX inhibitors - Mynewsdesk
How to Plan for Emergencies When You Have Hemophilia B - Everyday Health
Sustained Clinical Benefit of AAV Gene Therapy in Severe Hemophilia B - The New England Journal of Medicine
Concizumab approved to prevent or reduce the frequency of bleeding episodes in people aged 12 years and older with haemophilia A or B with inhibitors - GOV.UK
Hemophilia B gene therapy demonstrates long-term success - St. Jude Children's Research Hospital
First gene therapy to treat haemophilia B - European Medicines Agency (EMA)
Phase 1–2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B - The New England Journal of Medicine
FDA Expands Approval of Concizumab-mtci to Include Hemophilia A, B Without Inhibitor Use - Pharmacy Times – Pharmacy Practice News and Expert Insights
How Fitusiran Changes the Treatment Landscape in Hemophilia: Guy Young, MD - AJMC
With hemophilia B, a lifetime of worry eased with one infusion - Penn Today
Haemophilia A vs B: Which is more severe? Here’s what sets them apart - TheHealthSite
NMPA approves BBM and Takeda China’s haemophilia B therapy - Pharmaceutical Technology
Non-replacement therapy for people with haemophilia B: another step towards health equity - The Lancet
Case Report: Severe hemophilia B patient with inhibitor and anaphylaxis reaction to FIX, successfully managed with concizumab prophylaxis therapy - Frontiers
Hemophilia B Gene Therapy Shows Promise as Long-Term Treatment - Docwire News
Canadian first: One-time gene therapy given to London, Ont., hemophilia B patient - CTV News
Transformational therapy cures haemophilia B - BBC
CRISPR/Cas9-mediated genome editing via postnatal administration of AAV vector cures haemophilia B mice - Nature
CSL Behring treats two patients with gene therapy for haemophilia B - Clinical Trials Arena
CSL Behring Signs Letter of Intent with pan-Canadian Pharmaceutical Alliance (pCPA) for Public Reimbursement of HEMGENIX® (etranacogene dezaparvovec), the First Gene Therapy for Hemophilia B - Newswire Canada
Switching to Extended Half-Life Therapies Improves Hemophilia Care, but Raises Short-Term Costs - Managed Healthcare Executive
Therapeutic efficacy in a hemophilia B model using a biosynthetic mRNA liver depot system - Nature
Researchers welcome $3.5-million haemophilia gene therapy — but questions remain - Nature
Phase 3 Trial of Concizumab in Hemophilia with Inhibitors - The New England Journal of Medicine
Hemophilia B gene therapy benefits last more than a decade: Study - Hemophilia News Today
AAV gene therapy shows durable benefit in hemophilia B - 2 Minute Medicine
Spotlight on the ISTH Hemophilia Treatment Guidelines and Alternate Recommendations - Hematology Advisor
Hemophilia B Gene Therapy Produces Durable Response for 90% of Participants - AJMC
Breaking ground in haemophilia B gene therapy: insights from the HOPE-B trial and beyond - The Lancet
Pfizer’s hemophilia B gene therapy inches closer to regulatory approval - BioPharma Dive
Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B - The New England Journal of Medicine
Single-dose gene therapy is potentially life-changing for adults with hemophilia B - Penn Medicine
CSL doses first patient with haemophilia B gene therapy Hemgenix - Pharmaceutical Technology
First German haemophilia B patient receives gene therapy HEMGENIX - PharmaTimes
Experimental gene therapy for hemophilia B: Bill’s story - Children's Hospital of Philadelphia
Hemophilia B: Gene Therapy May Offer Cure for Many, Doctor Says - Business Insider
Higher Factor Activity Levels May Be Linked to Lower ABR, Better HRQoL in Hemophilia - Hematology Advisor
Consultation publique - FPS Public Health
Hemophilia gene therapy: A new era of treatment and the obstacles ahead - Drug Discovery News
Haemophilia gene therapy patients thriving over a decade after treatment - UCL | University College London
CRISPR/Cas9 for hemophilia - Hemophilia News Today
Haemophilia - The Lancet
Pfizer takes on haemophilia B gene therapy market with new FDA application - Pharmaceutical Technology
FDA approves first gene therapy for hemophilia B - BioPharma Dive
An Observational Study of Glycopegylated Extended Half-Life Factor Prophylaxis in Hemophilia A and B in a Tertiary Care Center in India - Cureus
A Case of Acquired Hemophilia A and Congenital Hemophilia B - Cureus
Gene therapy BBM-H901 approved for hemophilia B in China - Hemophilia News Today
NICE recommends weekly injection for severe haemophilia B - The Pharmaceutical Journal
uniQure announces FDA approval of first gene therapy for adults with hemophilia B - uniqure.gcs-web.com
Real Stories from People Living with Hemophilia - Centers for Disease Control and Prevention | CDC (.gov)
FDA Approves One-Time Gene Therapy Fidanacogene Elaparvovec for Hemophilia B - AJMC
After 4 years, hemophilia B bleeding rates remain low with Hemgenix - Hemophilia News Today
CSL’s haemophilia B therapy Hemgenix scores win authorisation in Canada - Pharmaceutical Technology
Characteristics of FXa-storing platelets in hemophilia B mice and the influence of alcohol on the platelets - Nature
Articles about Hemophilia - Centers for Disease Control and Prevention | CDC (.gov)
Foreign Language Equivalents
Foreign Language Equivalents of 'haemophilia b'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
hamophilia b,   haemohpilia b,   haenophilia b,   haemophillia b,   haemohilia b,   haemophiila b,   haeomphilia b,   hsemophilia b,   aemophilia b,   hemophilia b,   haemmophilia b,   gaemophilia b,   harmophilia b,   haemoohilia b,   haemophiia b,   haemophilis b,   haemophiliab,   haemopgilia b,   haemophulia b,   haemophilia bb,   haemophikia b,   haemophilia n,   haemophi;ia b,   haemo[hilia b,   haemophili ab,   haemopholia b,   haeophilia b,   haempphilia b,   haemophilia v,   hawmophilia b,   haemophila b,   haemophhilia b,   haemopphilia b,   haemophliia b,   haemopihlia b,   haaemophilia b,   haemophlia b,   haemphilia b,   haemophiliia b,   haemoophilia b,   hae,ophilia b,   haemophiliab ,   haeemophilia b,   haemophiliaa b,   haemophili b,   haemophilia ,   hhaemophilia b,   haemophilia b,   haemophilai b,   haemopjilia b,   haemophiloa b,   jaemophilia b,   heamophilia b,   haemophiilia b,   hameophilia b,   haempohilia b,   haemopilia b,   ahemophilia b,   haemophilua b,   haemiphilia b
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z